Llwytho...
Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells
Mobilized peripheral blood has become the primary source of hematopoietic stem and progenitor cells (HSPCs) for stem cell transplantation, with a 5-day course of granulocyte colony-stimulating factor (G-CSF) as the most common regimen used for HSPC mobilization. The CXCR4 inhibitor plerixafor is a m...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Clin Invest |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Society for Clinical Investigation
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6597242/ https://ncbi.nlm.nih.gov/pubmed/31085833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI124738 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|